GAMMA Investing LLC Grows Position in AdaptHealth Corp. (NASDAQ:AHCO)

GAMMA Investing LLC boosted its position in shares of AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 2,883.7% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 81,007 shares of the company's stock after acquiring an additional 78,292 shares during the quarter. GAMMA Investing LLC owned 0.06% of AdaptHealth worth $878,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Principal Financial Group Inc. grew its holdings in AdaptHealth by 204.0% during the fourth quarter. Principal Financial Group Inc. now owns 1,652,765 shares of the company's stock valued at $15,735,000 after purchasing an additional 1,109,021 shares during the period. Segall Bryant & Hamill LLC grew its holdings in AdaptHealth by 29.8% during the fourth quarter. Segall Bryant & Hamill LLC now owns 4,803,981 shares of the company's stock valued at $45,734,000 after purchasing an additional 1,102,173 shares during the period. Dimensional Fund Advisors LP grew its holdings in AdaptHealth by 17.6% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,379,715 shares of the company's stock valued at $32,174,000 after purchasing an additional 505,180 shares during the period. Bridgeway Capital Management LLC grew its holdings in AdaptHealth by 27.2% during the fourth quarter. Bridgeway Capital Management LLC now owns 1,324,043 shares of the company's stock valued at $12,605,000 after purchasing an additional 283,143 shares during the period. Finally, Royce & Associates LP grew its holdings in AdaptHealth by 29.0% during the fourth quarter. Royce & Associates LP now owns 1,002,755 shares of the company's stock valued at $9,546,000 after purchasing an additional 225,350 shares during the period. Hedge funds and other institutional investors own 82.67% of the company's stock.

AdaptHealth Price Performance

Shares of NASDAQ:AHCO traded down $0.03 on Wednesday, reaching $8.48. The company's stock had a trading volume of 1,335,629 shares, compared to its average volume of 1,291,632. AdaptHealth Corp. has a 52-week low of $7.11 and a 52-week high of $11.90. The company has a market cap of $1.14 billion, a P/E ratio of 11.66, a PEG ratio of 0.91 and a beta of 1.64. The company has a 50-day simple moving average of $8.63 and a 200 day simple moving average of $9.50. The company has a debt-to-equity ratio of 1.25, a quick ratio of 1.07 and a current ratio of 1.29.

Analyst Upgrades and Downgrades

Several research firms have issued reports on AHCO. Truist Financial cut their price target on AdaptHealth from $14.00 to $13.00 and set a "buy" rating for the company in a report on Monday, May 12th. Canaccord Genuity Group upped their price objective on AdaptHealth from $13.00 to $14.00 and gave the stock a "buy" rating in a research note on Wednesday, February 26th. Robert W. Baird upped their price objective on AdaptHealth from $14.00 to $16.00 and gave the stock an "outperform" rating in a research note on Thursday, February 27th. Finally, Royal Bank Of Canada dropped their price objective on AdaptHealth from $14.00 to $13.00 and set an "outperform" rating for the company in a research note on Thursday, May 8th. Five equities research analysts have rated the stock with a buy rating, According to MarketBeat, AdaptHealth currently has an average rating of "Buy" and a consensus price target of $13.40.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.